PET-CT Scanning for Multiple Myeloma Before CAR T-Cell Therapy
Part of Blood & lymphatic, Cancer, Heart & circulation, Immune system & allergy clinical trials.
This study uses advanced imaging (PET-CT scans) to help doctors better see multiple myeloma in patients who are about to receive CAR T-cell therapy. The goal is to improve how doctors detect and monitor the cancer using a newer type of scan.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have multiple myeloma and are planning to receive CAR T-cell therapy (Idecel or Ciltacel)
- You are at least 18 years old
- You can fast (not eat or drink) for at least 6 hours before your scan
- You can lie still on a scanner bed for up to 60 minutes without significant discomfort
- You are willing to have a bone marrow sample taken (a small needle procedure)
- You weigh 240 kg (about 530 lbs) or less
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging agent that may help doctors see multiple myeloma more clearly. It uses a special radioactive tracer that targets a protein found on myeloma cells, which could improve diagnosis and monitoring of the disease.
This study uses a special imaging test called a PET scan to learn more about multiple myeloma and how it responds to treatment. The results may help doctors better predict outcomes and tailor care for people with newly diagnosed disease.
This trial uses a special imaging agent (68Ga-NOTA-BCMA) to see where CAR-T cells go in your body. It aims to improve understanding of how well the therapy works. You must be planning to receive anti-BCMA CAR-T cell therapy for multiple myeloma.
This trial tests a new type of PET scan that uses a radioactive tracer (68Ga-BCMA) to find active multiple myeloma cells in your body. It may help doctors better detect and monitor the disease.
This trial compares two types of PET/CT scans to see which one better finds lesions (areas of disease) in people with newly diagnosed multiple myeloma. If you qualify, you may help doctors choose the most useful scan to guide care.
This trial tests a new type of immunotherapy called Multi-CAR T cells for people with multiple myeloma that has come back or not responded to other treatments. It aims to see if these specially engineered cells can better fight the cancer.
Hear when a new Multiple Myeloma (MM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.